Abstract
The blood-brain barrier (BBB) mediates interactions between the brain and the cytokines produced in the periphery. Some of these cytokines play significant roles in feeding behavior. This review will summarize various ways by which cytokines cross the BBB and discuss the implications of their transport systems in feeding. For simplicity of discussion, three categories of cytokines are discussed: (1) the proinflammatory cytokines TNFα, IFNγ, IL1, and IL6, (2) the chemokines MIP-1, CINC-1 and IL8, and (3) other cytokines (LIF, CNTF, GM-CSF, FGF, EGF, and TGFα). The pharmacokinetics of barrier penetration, compartmental distribution, stability, and mechanism of passage (presence or absence of saturable transport) are summarized. Our understanding of cytokines interacting with the BBB is still growing, not only are more cytokines being studied, but also more details of the nature of the transport systems and how they affect feeding behavior are being explored.
Keywords: Cytokines, chemokines, pharmacokinetics
Current Pharmaceutical Design
Title: Interactions of Cytokines with the Blood-Brain Barrier: Implications for Feeding
Volume: 9 Issue: 10
Author(s): Weihong Pan and Abba J. Kastin
Affiliation:
Keywords: Cytokines, chemokines, pharmacokinetics
Abstract: The blood-brain barrier (BBB) mediates interactions between the brain and the cytokines produced in the periphery. Some of these cytokines play significant roles in feeding behavior. This review will summarize various ways by which cytokines cross the BBB and discuss the implications of their transport systems in feeding. For simplicity of discussion, three categories of cytokines are discussed: (1) the proinflammatory cytokines TNFα, IFNγ, IL1, and IL6, (2) the chemokines MIP-1, CINC-1 and IL8, and (3) other cytokines (LIF, CNTF, GM-CSF, FGF, EGF, and TGFα). The pharmacokinetics of barrier penetration, compartmental distribution, stability, and mechanism of passage (presence or absence of saturable transport) are summarized. Our understanding of cytokines interacting with the BBB is still growing, not only are more cytokines being studied, but also more details of the nature of the transport systems and how they affect feeding behavior are being explored.
Export Options
About this article
Cite this article as:
Pan Weihong and Kastin J. Abba, Interactions of Cytokines with the Blood-Brain Barrier: Implications for Feeding, Current Pharmaceutical Design 2003; 9 (10) . https://dx.doi.org/10.2174/1381612033455332
DOI https://dx.doi.org/10.2174/1381612033455332 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Perioperative Handling of Antiplatelet Drugs. A Critical Appraisal
Current Drug Targets Improved Immunotoxins with Novel Functional Elements
Current Pharmaceutical Design Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Agonists as Therapeutic Agents for Cardiovascular Disorders: Focus on Atherosclerosis
Current Pharmaceutical Design Natriuretic Peptide Family: New Aspects
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Detection of Foxp3 Gene by DNA Hybridization Using A Hydrogel Based Sensor
Current Biotechnology Tolfenamic Acid Prevents Amyloid β-induced Olfactory Bulb Dysfunction In Vivo
Current Alzheimer Research TNF Receptor: Fc Fusion Protein Downregulates RANKL/OPG Ratio by Inhibiting CXCL16/CXCR6 in Active Ankylosing Spondylitis
Current Pharmaceutical Biotechnology Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
Current Cancer Drug Targets Therapeutic Targeting of Malignant Glioma
Anti-Cancer Agents in Medicinal Chemistry Mannose Binding Lectin: A Potential Biomarker for Many Human Diseases
Current Medicinal Chemistry New Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia
Current Pharmaceutical Biotechnology Mitochondrial Signal Transduction Abnormalities in Systemic Lupus Erythematosus
Current Immunology Reviews (Discontinued) Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets
Current Neuropharmacology Systemic Autoimmune Manifestations: When Should Underlying Thyroid Autoimmunity be Considered?
Current Rheumatology Reviews Chemokines in Gastrointestinal Disorders
Current Drug Targets Is There a Genetic Susceptibility to Bronchopulmonary Dysplasia?
Current Respiratory Medicine Reviews Pharmacokinetics of Antifungal Agents in Neonates and Young Infants
Current Medicinal Chemistry Transgenic Mouse Models of Alzheimer Disease: Developing a Better Model as a Tool for Therapeutic Interventions
Current Pharmaceutical Design Mechanisms of Colon Cancer Prevention with and Beyond COX-2 Inhibition
Current Topics in Medicinal Chemistry Inhibition of Key Fungal (02) Protein(s) (Aspergillus fumigatus) In-Response to Treatment with Poly-Acid Ligand
Current Proteomics